GLOBUS MEDICAL INC - A (GMED) Stock Balance Sheet
USA - NYSE:GMED - US3795772082 - Common Stock
83.99 USD
-0.72 (-0.85%)
83.99 USD
0 (0%)
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 371.77M | 784.44M | 467.29M | 150.50M | 193.10M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 18.75M | 105.62M | 50.50M | 295.60M | 250.40M | |||
| Receivables | 688.12M | 578.33M | 504.87M | 217.30M | 165.70M | |||
| Inventories | 771.54M | 659.23M | 848.13M | 299.00M | 237.00M | |||
| Other Current Assets | 74.18M | 49.64M | 44.58M | 21.00M | 18.40M | |||
| Total Current Assets | 1.92B | 2.18B | 1.92B | 983.30M | 864.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 637.92M | 612.07M | 647.66M | 243.70M | 226.10M | |||
| Investments And Advances | 16.68M | 66.13M | 75.43M | 495.90M | 562.50M | |||
| Goodwill | 1.43B | 1.43B | 1.43B | 197.50M | 179.70M | |||
| Intangibles | 773.90M | 795.12M | 924.60M | 63.60M | 68.70M | |||
| Other Non-Current Assets | 308.48M | 168.78M | 88.48M | 92.20M | 55.80M | |||
| Total Non-Current Assets | 3.17B | 3.07B | 3.17B | 1.09B | 1.09B | |||
| TOTAL ASSETS | 5.10B | 5.25B | 5.09B | 2.08B | 1.96B | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 344.00K | 443.58M | 475.00K | null | null | |||
| Accrued Expenses | 339.94M | 270.61M | 251.95M | 94.70M | 91.20M | |||
| Accounts Payable | 87.23M | 75.12M | 56.67M | 36.10M | 22.00M | |||
| Other Current Liabilities | 38.45M | 66.60M | 83.25M | 28.40M | 27.00M | |||
| Total Current Liabilities | 465.96M | 855.91M | 392.35M | 159.20M | 140.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 427.00K | 298.00K | 417.74M | 0 | 0 | |||
| Deferred Taxes/Income | 22.54M | 23.89M | 84.42M | 1.80M | 4.30M | |||
| Other Non-Current Liabilities | 207.89M | 194.32M | 193.62M | 68.80M | 71.40M | |||
| Total Non-Current Liabilities | 230.86M | 218.50M | 695.78M | 70.60M | 75.70M | |||
| TOTAL LIABILITIES | 696.82M | 1.07B | 1.09B | 229.80M | 215.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 1.29B | 1.15B | 1.14B | 1.24B | 1.19B | |||
| Additional Paid In Capital | 3.10B | 3.03B | 2.87B | 631.00M | 553.80M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 134.00K | 137.00K | 136.00K | 100.00K | 100.00K | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | 10.90M | -6.54M | -8.33M | -9.50M | -5.70M | |||
| Shares Outstanding | 134.61M | 137.42M | 136.34M | 100.20M | 101.50M | |||
| Tangible Book Value per Share | 16.2745 | 14.1888 | 12.0205 | 15.8214 | 14.7094 | |||
| Total Shareholders' Equity | 4.40B | 4.18B | 4.00B | 1.85B | 1.74B | |||
| TOTAL LIABILITIES AND EQUITY | 5.10B | 5.25B | 5.09B | 2.08B | 1.96B | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.10 | N/A | N/A | |||
| Current Ratio | 4.13 | 2.54 | 4.88 | 6.18 | 6.17 | |||
| Return On Assets (ROA) | 8.32% | 1.96% | 2.42% | 9.16% | 7.62% | |||
| Return On Equity (ROE) | 9.63% | 2.47% | 3.07% | 10.30% | 8.57% | |||
| Return On Invested Capital (ROIC) | 9.35% | 8.01% | 4.65% | 9.84% | 8.56% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 10.21% | 10.04% | 5.23% | 12.82% | 11.32% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 21.32% | 27.53% | 12.02% | 15.59% | 13.82% | |||
All data in USD , ROIC based on taxRate of 0.20